Recent weeks (and this week in particular) have been rough for pipeline products throughout the industry. A number of late stage trials failures. It's possible that this weighed on CGEN. Big pharma saw billions disappear overnight, and as we know they are very concerned regarding future prospects. In one sense this makes what Compugen offers even more attractive and potentially valuable. Yet at the same time CGEN has no insilica differentiated products in advanced trials where most of these products fail, so there remains a very significant risk. I would suggest there is a lot of "heart searching" going on behind closed doors in Big Pharma, as well as among the decision makers at the large investment firms. This seems a lot like high stakes gambling.
I'm sorry, but what are you trying to say? Your post sounds like the typical Wall Street analyst speaking out of both sides of his mouth at the same time. Calling CGEN "high stakes gambling" is as dam*ing a comment as one can make about a stock. Yet, your comment also talks of "prospects" that are "attractive and potentially valuable." If you are suggesting it's time to exit, please say so. While most of us are all too familiar with the risks (see 2007-2009), we do see this as a long term investment, not a high stakes gambling.
I had a bid in at 4.60 at the opening, hoping the panic selling would bring the price down to my bid. Somebody came in big at 4.63 which prevented my order from filling. Wow, had to laugh at that one. And the bounce back since has been incredibly swift and strong on volume. I'd say the signs are positive.